223 related articles for article (PubMed ID: 21369739)
41. Presence of functional axillary lymph nodes and lymph drainage within arms in women with and without breast cancer-related lymphedema.
Szuba A; Pyszel A; Jedrzejuk D; Janczak D; Andrzejak R
Lymphology; 2007 Jun; 40(2):81-6. PubMed ID: 17853618
[TBL] [Abstract][Full Text] [Related]
42. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
43. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery.
Goffman TE; Laronga C; Wilson L; Elkins D
Breast J; 2004; 10(5):405-11. PubMed ID: 15327493
[TBL] [Abstract][Full Text] [Related]
44. Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for Lymphedema Prevention after Axillary Lymph Node Dissection-A Single Institution Experience and Feasibility of Technique.
Lipman K; Luan A; Stone K; Wapnir I; Karin M; Nguyen D
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011833
[TBL] [Abstract][Full Text] [Related]
45. Lymphatic microsurgery to treat lymphedema: techniques and indications for better results.
Boccardo F; Fulcheri E; Villa G; Molinari L; Campisi C; Dessalvi S; Murdaca G; Campisi C; Santi PL; Parodi A; Puppo F; Campisi C
Ann Plast Surg; 2013 Aug; 71(2):191-5. PubMed ID: 23542829
[TBL] [Abstract][Full Text] [Related]
46. The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?
Lopez Penha TR; van Roozendaal LM; Smidt ML; Boersma LJ; von Meyenfeldt MF; Voogd AC; Heuts EM
Breast; 2015 Oct; 24(5):543-7. PubMed ID: 26051795
[TBL] [Abstract][Full Text] [Related]
47. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
48. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
49. Liposuction for Advanced Lymphedema: A Multidisciplinary Approach for Complete Reduction of Arm and Leg Swelling.
Boyages J; Kastanias K; Koelmeyer LA; Winch CJ; Lam TC; Sherman KA; Munnoch DA; Brorson H; Ngo QD; Heydon-White A; Magnussen JS; Mackie H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1263-70. PubMed ID: 26122375
[TBL] [Abstract][Full Text] [Related]
50. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer.
Bevilacqua JL; Kattan MW; Changhong Y; Koifman S; Mattos IE; Koifman RJ; Bergmann A
Ann Surg Oncol; 2012 Aug; 19(8):2580-9. PubMed ID: 22395997
[TBL] [Abstract][Full Text] [Related]
51. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
Beek MA; Gobardhan PD; Klompenhouwer EG; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2015 Jan; 41(1):59-63. PubMed ID: 25468747
[TBL] [Abstract][Full Text] [Related]
52. Time course of mild arm lymphedema after breast conservation treatment for early-stage breast cancer.
Bar Ad V; Cheville A; Solin LJ; Dutta P; Both S; Harris EE
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):85-90. PubMed ID: 19427748
[TBL] [Abstract][Full Text] [Related]
53. Lymphaticovenular bypass surgery for lymphedema management in breast cancer patients.
Chang DW
Handchir Mikrochir Plast Chir; 2012 Dec; 44(6):343-7. PubMed ID: 23007714
[TBL] [Abstract][Full Text] [Related]
54. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
55. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.
Boneti C; Badgwell B; Robertson Y; Korourian S; Adkins L; Klimberg V
Minerva Ginecol; 2012 Oct; 64(5):421-30. PubMed ID: 23018481
[TBL] [Abstract][Full Text] [Related]
56. Experimental and Analytical Comparisons of Tissue Dielectric Constant (TDC) and Bioimpedance Spectroscopy (BIS) in Assessment of Early Arm Lymphedema in Breast Cancer Patients after Axillary Surgery and Radiotherapy.
Lahtinen T; Seppälä J; Viren T; Johansson K
Lymphat Res Biol; 2015 Sep; 13(3):176-85. PubMed ID: 26305554
[TBL] [Abstract][Full Text] [Related]
57. Compression therapy in breast cancer-related lymphedema: A randomized, controlled comparative study of relation between volume and interface pressure changes.
Damstra RJ; Partsch H
J Vasc Surg; 2009 May; 49(5):1256-63. PubMed ID: 19394553
[TBL] [Abstract][Full Text] [Related]
58. Axillary lymph nodes and arm lymphatic drainage pathways are spared during routine complete axillary clearance in majority of women undergoing breast cancer surgery.
Szuba A; Chachaj Z; Koba-Wszedybylb M; Hawro R; Jasinski R; Tarkowski R; Szewczyk K; Bebenek M; Forgacz J; Jodkowska A; Jedrzejuk D; Janczak D; Mrozinska M; Pilch U; Wozniewski M
Lymphology; 2011 Sep; 44(3):103-12. PubMed ID: 22165580
[TBL] [Abstract][Full Text] [Related]
59. Combined Surgical Treatment in Breast Cancer-Related Lymphedema.
Masia J; Pons G; Nardulli ML
J Reconstr Microsurg; 2016 Jan; 32(1):16-27. PubMed ID: 25868153
[TBL] [Abstract][Full Text] [Related]
60. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.
Ponzone R; Cont NT; Maggiorotto F; Cassina E; Mininanni P; Biglia N; Sismondi P
J Clin Oncol; 2009 Nov; 27(33):5547-51. PubMed ID: 19826123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
